Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03709550
Title Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer
Recruitment Withdrawn
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Roswell Park Cancer Institute

prostate cancer


Decitabine + Enzalutamide

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.